Sex differences in systolic heart failure in the elderly: The prognostic importance of left ventricular mass in women

Journal of Women's Health

Volumn 17, Issue 3, 2008, Pages 373-381

  Mejhert, Marit ^a,b   Kahan, Thomas ^a   Edner, Magnus ^a   Persson, Hans Erik ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b ERSTA HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GERIATRIC PATIENT; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SEX DIFFERENCE; SYSTOLIC DYSFUNCTION; SYSTOLIC HEART FAILURE;

AGED; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; NEW YORK; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 41449116369     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2007.0487     Document Type: Article

References (40)

1. Ho K, Pinsky J, Kannel W, Levy D. The epidemiology of heart failure: The Framingham study. J Am Coll Cardiol 1993;22:6A.
2. Adams K, Dunlap S, Sueta C, et al. Relation beween gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996;28:1781.
3. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315.
4. Mejhert M, Homgren J, Wändell P, Persson H, Edner M. Diagnostic tests, treatment and follow-up in heart failure patients - Is there a gender bias in the coherence to guidelines? Eur J Heart Fail 1999;1:407.
5. The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429.
6. Garg R, Yusuf S, for the Collaborating Group on ACE-Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450.
7. Tamura T, Said S, Gerdes M. Gender-related differences in myocyte remodelling in progression to heart failure. Hypertension 1999;33:676.
8. Weinberg E, Tienelt C, Katz S, et al. Gender differences in molecular remodelling in pressure overload hypertrophy. J Am Coll Cardiol 1999;34:264.
9. Carroll J, Carroll E, Feldman T, et al. Sex-associated differences in left ventricular function in aortic stenosis in the elderly. Circulation 1992;86:1336.
10. Mejhert M, Kahan T, Persson H, Edner M. Limited long-term effects of a management programme for heart failure. Heart 2004;90:1010.
11. American Society of Echocardiography Committee. Recommendations for chamber quantification. J Am Soc Echocardiogr 2005;18:1440.
12. Devereux R, Reicher M. Echocardiographic determination of left ventricular mass in man. Circulation 1977;55:613.
13. Levy D, Savage D, Garrison R, et al. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol 1987;59:956.
14. Devereaux R, Dahlöf B, Levy D, Pfeffer M. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). Am J Cardiol 1996;78:61.
15. Koran M, Deveraux R, Casale P, Savage D, Laragh J. Relations of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345.
16. Verdecchia P, Porcellati C, Zampi I, Schillaci G, Gatteschi C. Asymmetric left ventricular remodelling due to isolated septal thickening in patients with systemic hypertension and normal left ventricular masses. Am J Cardiol 1994;73:247.
17. Höglund C, Alam M, Thorstrand C. Atrioventricular valve plane displacement in healthy persons: An echocardiographic study. Acta Med Scand 1988;224:557.
18. Redfield M, Jacobsen S, Burnett J, et al. Burden of systolic and diastolic ventricular dysfunction in the community. JAMA 2003;289:194.
19. Persson H, Lonn E, Edner M. Diastolic dysfunction in heart failure with preserved systolic function - Need for objective evidence. Results from the CHARM Echocardiographic Substudy - CHARMES. J Am Coll Cardiol 2007;49:687.
20. Mantero A, Gentile F, Gualtierotti C, et al. Left ventricular diastolic parameters in 288 normal subjects from 20 to 80 years old. Eur Heart J 1995;16:94.
21. Rakowski H, Appleton C, Chan K-L, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography. J Am Soc Echocardiogr 1996;9:736.
22. Oh J, Appleton C, Hatle L, Nishimura R, Seward J, Tajik A. The non-invasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997;10:246.
23. Del Ry, Clerico A, Gianess D. Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an IRMA method. Scand J Clin Lab Invest 2000;60:81.
24. Croft J, Giles W, Pollard R, et al. Heart failure survival among older adults in the United States: A poor prognosis for an emerging epidemic in the Medicare population. Arch Intern Med 1999;159:505.
25. Kirkwood F, Dunlap S, Sueta C. Relation between gender, aetiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996;7:1781.
26. Kimmelstiel C, Konstam M. Heart failure in women. Cardiology 1995;86:304.
27. Wachtell K, Bella J, Liebson P, et al. Impact of different partition values on prevalence of left ventricular hypertrophy and concentric geometry in a large hypertensive population. The LIFE study. Hypertension 2000;3:6.
28. McKee P, Castelli W, McNamara P, Kannel W. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971;285:1441.
29. Mendes L, Davidoff R, Cupples A, Ryan T, Jacobs K. Congestive heart failure in patients with coronary artery disease: The gender paradox. Am Heart J 1997;134:207.
30. Luchner A, Brockel U, Muscholl M, et al. Gender-specific differences of cardiac remodelling in subjects with left ventricular dysfunction: A population-based study. Cardiovasc Res 2002;15:720.
31. de Simone G, Devereux R, Daniels S, Meyer R. Gender differences in left ventricular growth. Hypertension 1995;26:979.
32. Ganau A, Saba P, Roman M, et al. Ageing induces left ventricular concentric remodelling in normotensive subjects. J Hypertens 1995;13:1818.
33. Hees P, Fleg J, Lakatta E, Shapiro E. Left ventricular remodelling with age in normal men versus women: Novel insights using three-dimensional magnetic resonance imaging. Am J Cardiol 2002;90:1231.
34. Gardner J, Brower G, Janiciki J. Gender differences in cardiac remodelling secondary to chronic volume overload. J Cardiac Fail 2002;2:101.
35. Pelzer T, Jazbutyte V, Hu K, et al. The oestrogen receptor-α agonist 16α-LE2 inhibits cardiac hypertrophy and improves homodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovasc Res 2005;67:604.
36. Pelzer T, Loza P, Hu K, et al. Increased mortality and aggravation of heart failure in oestrogen receptor β knockout mice after myocardial infarction. Circulation 2005;12:1492.
37. Cowburn P, Cleland J, Coats A, Komajda M. Risk stratification in chronic heart failure. Eur Heart J 1998;5:696.
38. Martinez-Selles M, Robles J, Prieto L. Systolic dysfunction is a predictor of long-term mortality in men but not in women with heart failure. Eur Heart J 2003;24:2046.
39. Bettencourt P, Ferreira S, Azavedo A, Ferreira A. Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure. Am J Med 2002;113:215.
40. Konstam V, Salem D, Pouleur H, et al. Baseline quality of life as a predictor of mortality and hospitalization in 5025 patients with congestive heart falure. Am J Cardiol 1996;78:890.